Conclusion: Although some pharmacotherapeutic modalities, particularly benzodiazepines, appear to be safe and efficacious for reducing some measures of alcohol withdrawal, methodological issues and a high risk of bias prevent a consistent estimate of their comparative performance.
PubMed 35194860 ↗Lorazepam
Also known as Ativan
The short answer. More people than not who report on Lorazepam say it helped (66% of 20). It is most often used for anxiety: 100% of 19 reports say that improved. It is well studied — 115 meta-analyses on PubMed.
From 31 mentions in total — the rest didn't say how it went and aren't counted.
What Lorazepam does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 115 meta-analyses on PubMed ↗ · 650 randomized trials ↗
Conclusion: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: acupuncture, amantadine, baclofen, benzatropine, biofeedback, botulinum toxins, bromocriptine, carbamazepine, carbidopa/levodopa, clonazepam, clozapine, deep brain stimulation of thalamus and globus pallidus, diazepam, gabapentin, haloperidol, lorazepam, myectomy (for focal dystonia), occupational therapy, ondansetron, physiotherapy, pregabalin, procyclidine, selective peripheral denervation (for focal dystonia), speech therapy, tizanidine, trazodone hydrochloride, and tri
PubMed 25347760 ↗Conclusion: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine), antidepressants (clomipramine, fluoxetine, imipramine, sertraline), antipsychotics (haloperidol, olanzapine, quetiapine, risperidone), aromatherapy, benzodiazepines (diazepam, lorazepam), cognitive behavioural therapy (CBT), cognitive stimulation, exercise, ginkgo biloba, memantine, mood stabilisers (carbamazepine, sodium valproate/valproic acid), music therapy, non-steroidal anti-inflammatory drugs (N
PubMed 23870856 ↗Conclusion: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine), antidepressants (clomipramine, fluoxetine, imipramine, sertraline), antipsychotics (haloperidol, olanzapine, quetiapine, risperidone), aromatherapy, benzodiazepines (diazepam, lorazepam), cognitive behavioural therapy (CBT), cognitive stimulation, exercise, ginkgo biloba, memantine, mood stabilisers (carbamazepine, sodium valproate/valproic acid), music therapy, non-steroidal anti-inflammatory drugs (N
PubMed 21726471 ↗183 human trials on ClinicalTrials.gov test Lorazepam — 105 completed, 15 recruiting now. See all on ClinicalTrials.gov ↗
- Multimodal Analgesia Effect on Post Surgical Patient · Obesity, Morbid, Surgery · 2025
- Therapies for Down Syndrome Regression Disorder · Down Syndrome, Regression · 2026
- Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis · Schizophrenia, Bipolar Disorder · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Lorazepam is a Schedule IV controlled substance in the US. DEA controlled-substance list ↗
Boxed warning (the FDA's strongest label warning): “RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for…”
20 recalls of products named for Lorazepam. Most recent:
- 2025-08-06 · Class II: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds record ↗
- 2025-03-12 · Class II: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. record ↗
- 2025-02-26 · Class II: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
178,731 adverse-event reports mention Lorazepam. Most often reported:
- Fatigue · 13,819
- Nausea · 13,646
- Drug ineffective · 12,492
- Diarrhoea · 10,646
- Off label use · 10,585
- Dyspnoea · 9,490
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Lorazepam D — a possible rare cause of liver injury (1–3 published cases). LiverTox entry ↗
NIH has funded 20 research projects with Lorazepam in the title, $10,186,683 in total (1990–2016). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Lorazepam ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“lorazepam works quite well (only thing I've tried so far that works)”
“it isn't potentially addictive like lorazepam, the other thing that works well for me.”
“the only thing which has been helping me feel like 'myself' at all and be able to function in social situations is when I take 0.5 of ativan or klonopin”
“I was given the Ativan at the hospital a few weeks ago which has made me calm down”
Top discussions (5)
Other options for anxiety
Sources
- User reports: 31 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- US DEA ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate